These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4832602)

  • 1. Evidence for a urate reabsorptive defect in patients with Wilson's disease.
    Wilson DM; Goldstein P
    Adv Exp Med Biol; 1974; 41():729-37. PubMed ID: 4832602
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal urate excretion in patients with Wilson's disease.
    Wilson DM; Goldstein NP
    Kidney Int; 1973 Nov; 4(5):331-6. PubMed ID: 4762580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of penicillamine therapy on uric acid metabolism in Wilson's disease.
    Sorensen LB; Kappas A
    Trans Assoc Am Physicians; 1966; 79():157-64. PubMed ID: 5954284
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal clearances of different amino acids in Wilson's disease before and after treatment with penicillamine.
    Schonheyder F; Gregersen G; Hansen HE; Skov PE
    Acta Med Scand; 1971 Nov; 190(5):395-9. PubMed ID: 5149266
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal function in Wilson's disease: response to penicillamine therapy.
    Leu ML; Strickland GT; Gutman RA
    Am J Med Sci; 1970 Dec; 260(6):381-98. PubMed ID: 5511397
    [No Abstract]   [Full Text] [Related]  

  • 7. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result].
    Hamza B; el-Kamel M
    Tunis Med; 1974; 52(1):29-31. PubMed ID: 4215182
    [No Abstract]   [Full Text] [Related]  

  • 8. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urine copper determination in Wilson's disease during therapy].
    Schnack H
    Wien Z Inn Med; 1967; 48(12):469-76. PubMed ID: 5620588
    [No Abstract]   [Full Text] [Related]  

  • 10. Penicillamine in Wilson's disease.
    Danks DM
    Lancet; 1982 Aug; 2(8295):435-6. PubMed ID: 6124819
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients.
    Umeki S; Ohga R; Konishi Y; Yasuda T; Morimoto K; Terao A
    Am J Med Sci; 1986 Nov; 292(5):289-92. PubMed ID: 3777013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of the tryptophan-nicotinic acid pathway by penicillamine-induced pyridoxine deficiency in patients with Wilson's disease and in experimental animals.
    Gibbs K; Walshe JM
    Ann N Y Acad Sci; 1969 Sep; 166(1):158-69. PubMed ID: 5262012
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with long-term therapy of Wilson's disease].
    Schindler H
    Wien Z Inn Med; 1967; 48(12):465-9. PubMed ID: 5620587
    [No Abstract]   [Full Text] [Related]  

  • 15. Brief observations on the management of Wilson's disease.
    Walshe JM
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):1-3. PubMed ID: 122651
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the 198Au liver scan in assessing the therapeutic effect of penicillamine in Wilson's disease.
    Chajek T
    Postgrad Med J; 1974 Jan; 50(579):56-8. PubMed ID: 4464503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of penicillamine on failure of renal acidification in Wilson's disease.
    Walshe JM
    Lancet; 1968 Apr; 1(7546):775-8. PubMed ID: 4171128
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma copper and antioxidant status in Wilson's disease.
    Ogihara H; Ogihara T; Miki M; Yasuda H; Mino M
    Pediatr Res; 1995 Feb; 37(2):219-26. PubMed ID: 7731761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease.
    Hoppe B; Neuhaus T; Superti-Furga A; Forster I; Leumann E
    Nephron; 1993; 65(3):460-2. PubMed ID: 8290000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.